RESEARCH TO PREVENT MEMORY LOSS

Dementia Research Switzerland - Synapsis Foundation is a non-profit, tax-exempt foundation under Swiss law. The foundation is under the authority of the Federal Department of Home Affairs. The foundation was established 21 years ago on the basis of the realisation that research on dementia, particularly Alzheimer's, has become increasingly important in light of recent demographic developments.

OUR OBJECTIVE

The Synapsis Foundation was established to support research on dementia and other neurodegenerative disorders in Switzerland. We primarily focus on research into Alzheimer's disease, the most common form of dementia. By pooling resources, we hope to have a lasting impact, one day hopefully leading to a cure for Alzheimer’s.

OUR WORK

Generally, research is largely funded by the state and private sector. We recognise the need to invest additional funds into researching dementia, particularly Alzheimer's, to find a cure in the near future. Our work also helps promote Switzerland as a research and business location by supporting the establishment of young research groups.

OUR RESPONSIBILITY

We take steps to ensure that the funds entrusted to us are used as intended to improve our understanding of the causes behind Alzheimer’s and other neurodegenerative disorders and to find new evidence for their diagnosis and treatment. Our Scientific Advisory Board is instrumental in selecting the best research projects and following their progress.

HOW WE WORK

Our donors, boards and researchers work hand in hand towards a common goal – a world in which Alzheimer’s can be stopped in its tracks. We engage in targeted fundraising activities to reach out to private and institutional donors. Thanks to their generous support, we have been able to make a key contribution to the research of neurodegenerative disorders.

Offices

The employees at our offices are the first point of contact for any queries you may have. They maintain relationships with our donors. Our offices provide a hub for the Board of Trustees, Scientific Advisory Board and researchers. Our employees are responsible for ensuring that all of the foundation's work is carried out in line with our statute and the law.

Corinne Denzler

Managing Director / Institutional Fundraising
denzler_at_demenz-forschung.ch

Franziska Czerny

Administration & Donation Services
info_at_demenz-forschung.ch

Heide Marie Hess

Liaison Officer Research
hess_at_demenz-forschung.ch

Matthias Durrer

Institutional Fundraising & Legacies
durrer_at_demenz-forschung.ch

Andrea Traber

Public Fundraising & Communications
traber_at_demenz-forschung.ch

Kevin Duarte Carneiro

Digitalisation & Administration
duarte_at_demenz-forschung.ch

OUR BOARD OF TRUSTEES

Our honorary Board of Trustees is responsible for the strategic orientation of the foundation, monitoring the foundation's activities and granting funding for research projects based on the recommendations of our Scientific Advisory Board. With a wide range of expertise in the fields of medicine, research, communication, law, science management and finance, the Board of Trustees is able to make sound decisions on all foundation matters.

MEMBERS OF THE BOARD OF TRUSTEES (FROM LEFT TO RIGHT)

Dr. Margrit Leuthold
President

Alberto Cominetti
CEO of Cominetti International GmbH, Member of ZWEI Wealth Experts AG, Zurich

Prof. Dr. iur. utr. Brigitte Tag
Full Professor, Chair of Criminal Law, Criminal Proceedings and Medical Law, University of Zurich

Prof. Andreas Lüthi
Professor at Friedrich Miescher Institute for Biomedical Research

Dr. Daniel Vonder Mühll
Director of Personalized Health and Related Technologies, ETH Zurich

Dr. Theres Lüthi
Science Editor

Scientific Advisory Board

Our Scientific Advisory Board consists of internationally acclaimed experts from the field of brain disorders. It advises the Board of Trustees on all scientific matters and plays a central role in selecting and following projects that receive funding.